The Recall Desk
HighFDA (Drugs)·D-0416-2025·Announced 2025-05-14

Testosterone Pellets Recalled for Glass Particle Contamination

BSO LLC is recalling testosterone pellets containing glass particles found in vials. The contamination poses a risk to patients receiving subcutaneous injections.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The presence of glass particles in an injectable product poses a direct risk of harm to patients, fitting the rubric criterion for 'risk-of-harm products where injury has not yet been reported.'

Plain-English summary

BSO LLC has initiated a nationwide recall of testosterone pellets due to the presence of glass particles found in vials. The product is a compounded testosterone formulation (200 mg per pellet) intended for subcutaneous injection.

The affected lots are Lot 20250129@1 (expiration 1/17/2026) and Lot 20250218@4 (expiration 1/25/2026). Approximately 1,964 vials of the product are included in this recall.

Patients who have received this product should consult with their healthcare provider regarding their treatment history with these testosterone pellets.

The recalled product

Product
TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01
Manufacturer
BSO LLC
Category
Drug — Compounded Testosterone
Hazard
  • glass-particles
  • contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot 20250129@1
  • exp 1/17/2026
  • Lot 20250218@4
  • exp 1/25/2026

Distribution

Distributed nationwide across the United States.

Related recalls

Same category